Skip to content
TrialScanner

NCT05275478

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Phase 1/Phase 2TerminatedTNGXLead

Registry record

Lead sponsor
Tango Therapeutics, Inc.
Conditions
Locally Advanced Solid Tumor
Primary completion
Dec 30, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05275478 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.